Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FN4HL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,897
Award facts
- Contract value 100% obligated
- $19,897.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,897.15 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound (tirzepatide) is a GLP-1 receptor agonist medication used for weight management and diabetes treatment, representing part of the federal government's pharmaceutical procurement needs for military and healthcare system operations.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a total potential value of $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of medications and medical commodities to support military healthcare programs and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen consistently delivers specialized medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains through its extensive contract portfolio with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FN4HL?
SPE2DB25FN4HL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FN4HL worth?
The government has obligated $19,897 on SPE2DB25FN4HL.
Is contract SPE2DB25FN4HL an order under another contract?
Yes. SPE2DB25FN4HL is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4HL competed?
The extent of competition for SPE2DB25FN4HL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award